Fundraising Fox
Valio
Techstars '25Zionsville, US · Founded 2020 · 2 employees on LinkedIn · 1 known investors
Find your way into Valio
Sign up to see every warm intro you have to Valio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Valio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Valio provides an AI platform that analyzes rebate contracts and purchase order history for health systems to identify unclaimed rebate savings, verify vendor payments, and optimize rebate distribution across hospitals.
Also known as Valio LLC
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Valio (Valio LLC, myvalio.com) offers an AI platform for health systems that converts rebate contract terms into actionable savings analysis. The company imports a customer's rebate terms on their behalf, after which the hospital uploads its Purchase Order History (POH) file each month. Valio then compares agreements against actual spend to surface additional savings available from purchasing more units by a given deadline, to confirm that the vendor paid the rebate correctly, and to determine how rebate savings should be distributed across hospitals within a system. The company states that uploaded files are kept secure and private and that it will sign an NDA where required.
Beyond rebate analysis, Valio markets a supply-chain workflow product covering new product requests and evaluation. Physicians submit a brief product request, which is routed to the relevant sales representative for pricing and additional detail; supply chain staff then review a Valio ROI report comparing the proposed product with the incumbent on both financial and evidence-based clinical dimensions. Follow-up tooling includes a trial tracker with mobile feedback submission that feeds an automated trial report, a lookback report assessing whether a product delivered its anticipated benefits, and a rebate tracker that monitors earned rebates and suggests optimal order timing. Third-party coverage describes the company as automating the rebate-contract compliance disputed between hospitals and their suppliers.
Business model
Valio sells access to its platform on a subscription basis; its terms of use reference a Platform Subscription Agreement and paid Subscriptions granting access to the site and platform, with customers able to register for login credentials.
Platform subscriptions purchased by customer organizations under a Subscription Agreement.
Traction
Selected for a Techstars AI Health accelerator in 2025; the website refers to unnamed backers under a "backed by" section.
Latest developments
In 2025 Valio was selected for a Techstars AI Health accelerator and was included in a field guide to Indianapolis-area startups to watch.
▸Full profile — market position, technology, go-to-market
Market position
Listed among early-stage Indianapolis-area companies "earning their first attention" in a regional startup roundup, placed below peers that have disclosed institutional funding rounds.
Technology
An AI-based platform that ingests rebate contract terms and monthly hospital Purchase Order History files, reconciles contracted rebate terms against actual purchasing, and generates savings, payment-verification, ROI, trial and lookback reports.
Go-to-market
Direct sales led by demo requests on the company website, supported by participation in a Techstars AI Health accelerator in 2025.
Health systems and hospitals, including their supply chain teams, physicians submitting product requests, and the vendor sales representatives who supply pricing information.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsValio was selected for a Techstars AI Health accelerator in 2025.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Valiomyvalio.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Valio do?
- AI platform that turns hospital rebate contracts and purchase order history into identified and verified rebate savings.
- Who are Valio's investors?
- Valio's investors include Techstars.
- Where is Valio headquartered?
- Valio is headquartered in Zionsville, US.